NuvOx was honored with the AZBIO Fast Lane Award for the company's many achievements in the last 18 months. The award committee noted the company's advancements in clinical trials for brain cancer and stroke, and continued development in pre-clinical stage indications such as heart attack.
top of page
Search
Recent Posts
See AllNuvOx Announces Two New Publications Tucson, AZ – October 21, 2024 - Co-Founders, Dr. Evan Unger and Dr. Jennifer LH Johnson combine...
Tucson, AZ – October 9, 2024 - Dr. Evan Unger, Executive Chairman of NuvOx Therapeutics (NuvOx), has been awarded the 2024 Harry Fischer...
Tucson, AZ, September 6th, 2024 – NuvOx Pharma LLC, a wholly owned subsidiary of NuvOx Therapeutics Inc. (together, “NuvOx”) announced...
bottom of page
Comments